{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:31:54Z","timestamp":1791246714911,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ahj.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T14:03:02Z","timestamp":1533218582000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct"],"prefix":"10.1016","volume":"206","author":[{"given":"Philip","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L","family":"Dans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Lopez-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Yusoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Santoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Gamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Camacho","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tyrwhitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ahj.2018.07.012_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/eurheartj\/eht407","article-title":"Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges","volume":"35","author":"Working Group on the Summit on Combination Therapy for CVD","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.07.012_bb0010","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases","volume":"3","author":"Bahiru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.012_bb0015","first-page":"311","article-title":"Novel approaches in primary cardiovascular disease prevention: The HOPE-3 Trial rationale, design, and participants' baseline characteristics","volume":"32","author":"Lonn","year":"2016","journal-title":"Can J Cardiol"},{"issue":"21","key":"10.1016\/j.ahj.2018.07.012_bb0020","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090286","article-title":"Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2018.07.012_bb0030","series-title":"Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]","author":"Guirguis-Blake","year":"2015"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.012_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/nu6020729","article-title":"Vitamin D deficiency in India: prevalence, causalities and interventions","volume":"6","author":"Ritu","year":"2014","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.012_bb0040","first-page":"538","article-title":"25-hydroxy-vitamin D demography and the risk of vitamin D insufficiency in the South East Asian Nutrition Surveys (SEANUTS)","volume":"25","author":"Poh","year":"2016","journal-title":"Asia Pac J Clin Nutr"},{"issue":"7","key":"10.1016\/j.ahj.2018.07.012_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/heartjnl-2017-311609","article-title":"Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world","volume":"104","author":"Joseph","year":"2018","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.012_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurheartj\/ehq448","article-title":"Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score","volume":"32","author":"McGorrian","year":"2011","journal-title":"Eur Heart J"},{"issue":"10013","key":"10.1016\/j.ahj.2018.07.012_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(15)00469-9","article-title":"Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"387","author":"Khatib","year":"2016","journal-title":"Lancet"},{"issue":"9798","key":"10.1016\/j.ahj.2018.07.012_bb0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.012_bb0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/ija.IJA_143_17","article-title":"Regulatory requirements for clinical trials in India: What academicians need to know","volume":"61","author":"Gogtay","year":"2017","journal-title":"Indian J Anaesth"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.012_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0970-0218.143018","article-title":"Clinical trials: changing regulations in India","volume":"39","author":"Saxena","year":"2014","journal-title":"Indian J Community Med"},{"issue":"9","key":"10.1016\/j.ahj.2018.07.012_bb0075","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.012_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084238","article-title":"Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies","volume":"9","author":"Khatib","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ahj.2018.07.012_bb0085","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(17)30141-X","article-title":"Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"2","author":"Attaei","year":"2017","journal-title":"Lancet Public Health"},{"issue":"6","key":"10.1016\/j.ahj.2018.07.012_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ahj.2018.07.012_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ Res"},{"issue":"9672","key":"10.1016\/j.ahj.2018.07.012_bb0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial","volume":"373","author":"The Indian Polycap Study (TIPS)","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.012_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCOUTCOMES.111.963637","article-title":"Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators","volume":"5","author":"Yusuf","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2018.07.012_bb0110","author":"Ilancheran"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:40Z","timestamp":1757570500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":22,"alternative-id":["S0002870318302229"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}